Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Selitrectinib |
| Trade Name | |
| Synonyms | LOXO-195|BAY 2731954 |
| Drug Descriptions |
Selitrectinib (LOXO-195) is an inhibitor of NTRK1, NTRK2, and NTRK3, which may result in inhibition of tumor growth and tumor regression (PMID: 28578312). |
| DrugClasses | Trk Receptor Inhibitor (Pan) 33 |
| CAS Registry Number | 2097002-61-2 |
| NCIT ID | C138160 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Crizotinib + Selitrectinib | Crizotinib Selitrectinib | 0 | 0 |
| Dabrafenib + Selitrectinib + Trametinib | Dabrafenib Selitrectinib Trametinib | 0 | 0 |
| Selitrectinib | Selitrectinib | 0 | 1 |
| Selitrectinib + Trametinib | Selitrectinib Trametinib | 0 | 0 |